Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |